Supplemental Evidence and Data Request on Updating the Framework for AHRQ's National Healthcare Quality and Disparities Report (NHQDR), 71866-71867 [2023-22915]
Download as PDF
<![CDATA[
71866
Federal Register / Vol. 88, No. 200 / Wednesday, October 18, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Updating the Framework
for AHRQ’s National Healthcare Quality
and Disparities Report (NHQDR)
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for Supplemental
Evidence and Data Submission.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review on
Updating the Framework for AHRQ’s
National Healthcare Quality and
Disparities Report (NHQDR), which is
currently being conducted by the
AHRQ’s Evidence-based Practice
Centers (EPC) Program. Access to
published and unpublished pertinent
scientific information will improve the
quality of this review.
DATES: Submission Deadline on or
before November 17, 2023.
ADDRESSES:
Email submissions: epc@
ahrq.hhs.gov.
Print submissions:
Mailing Address: Center for Evidence
and Practice Improvement, Agency for
Healthcare Research and Quality,
ATTN: EPC SEADs Coordinator, 5600
Fishers Lane, Mail Stop 06E53A,
Rockville, MD 20857.
Shipping Address (FedEx, UPS, etc.):
Center for Evidence and Practice
Improvement, Agency for Healthcare
Research and Quality, ATTN: EPC
SEADs Coordinator, 5600 Fishers Lane,
Mail Stop 06E77D, Rockville, MD
20857.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
ddrumheller on DSK120RN23PROD with NOTICES1
Kelly Carper, Telephone: 301–427–1656
or Email: epc@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Updating the Framework
for AHRQ’s National Healthcare Quality
VerDate Sep<11>2014
18:01 Oct 17, 2023
Jkt 262001
and Disparities Report (NHQDR). AHRQ
is conducting this review pursuant to
Section 902 of the Public Health Service
Act, 42 U.S.C. 299a.
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Updating the Framework
for AHRQ’s National Healthcare Quality
and Disparities Report (NHQDR). The
entire research protocol is available
online at: https://
effectivehealthcare.ahrq.gov/products/
updating-framework/protocol.
This is to notify the public that the
EPC Program would find the following
information on Updating the Framework
for AHRQ’s National Healthcare Quality
and Disparities Report (NHQDR)
helpful:
D A list of completed studies that
your organization has sponsored for this
topic. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov, a
summary, including the following
elements, if relevant: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
D A list of ongoing studies that your
organization has sponsored for this
topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including, if relevant, a study
number, the study period, design,
methodology, indication and diagnosis,
proper use instructions, inclusion and
exclusion criteria, and primary and
secondary outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
organization for this topic and an index
outlining the relevant information in
each submitted file.
Your contribution is very beneficial to
the Program. Materials submitted must
be publicly available or able to be made
public. Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on topics not included in
the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program website and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://
www.effectivehealthcare.ahrq.gov/
email-updates.
The review will answer the following
questions. This information is provided
as background. AHRQ is not requesting
that the public provide answers to these
questions.
Guiding Questions (GQ)
GQ1. Which frameworks have been
developed or are used for quality of
care?
• What settings, populations, and
intended use were the frameworks
developed for?
• How are the framework domains
defined?
• In what context have these
frameworks been used?
• How do these frameworks intersect
with levers and tools available to federal
and state governments?
• How are the frameworks and
domains similar or different from the
2010 NASEM framework?
GQ2. How should the 2010 NASEM
framework and its domains be updated?
• How would existing AHRQ NHQDR
measures be reorganized in the updated
framework and domains?
• Are there available measures for
new framework domains?
Æ Describe measures in terms of their
definition, population, years available,
geographic representation, data sources,
and supporting evidence.
E:\FR\FM\18OCN1.SGM
18OCN1
71867
Federal Register / Vol. 88, No. 200 / Wednesday, October 18, 2023 / Notices
CRITERIA FOR INCLUSION/EXCLUSION OF STUDIES IN THE REVIEW
Domain
Inclusion
Exclusion
Population ..................
• Publications that address quality of care indicators, criteria, or benchmarks. We will
accept the authors’ definition of quality of care. Quality indicators may include care
processes-related measures (e.g., follow-up post discharge, continuity of care,
medication errors), heath services utilization measures (e.g., hospital readmission,
emergency department visit), care satisfaction (e.g., patient satisfaction, care needs
met, trust in care provider), or health outcomes (e.g., mortality, physical functional
status, mental functioning, quality of life) used as quality indicators. Publications
that do not address quality of care in detail but include quality of care and health
equity in a framework will also be eligible. Care disparities may either address differences in provided health services, focus on care services or health outcomes of
priority populations.
• Publications that include a figure or detailed description of a framework of quality of
care or care disparities; frameworks may use the format of a logic model, analytic
framework, conceptual model, or other conceptualizations of quality of care.
• Publications not addressing
quality of care and publications not mentioning quality of
care nor health equity as a
central feature of a framework.
Concept .....................
Context ......................
• Healthcare, specifically healthcare delivery organizations ..........................................
Other limiters .............
• Reports published in English-language, journal manuscripts, trial records, and gray
literature in the public domain from the outlined sources.
Dated: October 12, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–22915 Filed 10–17–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ddrumheller on DSK120RN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to section 5 U.S.C.
Section1009(d), notice is hereby given
of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)CE24–013, Research Grants to Identify
VerDate Sep<11>2014
18:01 Oct 17, 2023
Jkt 262001
Effective Community-Based Strategies
for Overdose Prevention (R01).
Date: March 12–13, 2024.
Time: 8:30 a.m.–5 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341,
Telephone: (404)639–6473; Email:
AWilkes@cdc.gov.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–23006 Filed 10–17–23; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
• Publications citing existing
frameworks without further
conceptual contribution to the
framework and publications
describing only the need of
quality of care measures.
• Studies in contexts outside of
healthcare or not specific to
healthcare.
• Data reported in abbreviated
format (e.g., conference abstracts) will be excluded;
studies not published in
English
• Systematic reviews will be retained for reference mining.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE24–029, Grants to Support New
Investigators in Conducting Research
Related to Preventing Interpersonal
Violence Impacting Children and Youth.
Date: March 19, 2024.
Time: 8:30 a.m.–5 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\18OCN1.SGM
18OCN1
]]>Agencies
[Federal Register Volume 88, Number 200 (Wednesday, October 18, 2023)]
[Notices]
[Pages 71866-71867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22915]
[[Page 71866]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Updating the Framework
for AHRQ's National Healthcare Quality and Disparities Report (NHQDR)
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for Supplemental Evidence and Data Submission.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review on Updating the
Framework for AHRQ's National Healthcare Quality and Disparities Report
(NHQDR), which is currently being conducted by the AHRQ's Evidence-
based Practice Centers (EPC) Program. Access to published and
unpublished pertinent scientific information will improve the quality
of this review.
DATES: Submission Deadline on or before November 17, 2023.
ADDRESSES:
Email submissions: [email protected].
Print submissions:
Mailing Address: Center for Evidence and Practice Improvement,
Agency for Healthcare Research and Quality, ATTN: EPC SEADs
Coordinator, 5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857.
Shipping Address (FedEx, UPS, etc.): Center for Evidence and
Practice Improvement, Agency for Healthcare Research and Quality, ATTN:
EPC SEADs Coordinator, 5600 Fishers Lane, Mail Stop 06E77D, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: Kelly Carper, Telephone: 301-427-1656
or Email: [email protected].
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality has commissioned the Evidence-based Practice Centers (EPC)
Program to complete a review of the evidence for Updating the Framework
for AHRQ's National Healthcare Quality and Disparities Report (NHQDR).
AHRQ is conducting this review pursuant to Section 902 of the Public
Health Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the literature by requesting information from the
public (e.g., details of studies conducted). We are looking for studies
that report on Updating the Framework for AHRQ's National Healthcare
Quality and Disparities Report (NHQDR). The entire research protocol is
available online at: https://effectivehealthcare.ahrq.gov/products/updating-framework/protocol.
This is to notify the public that the EPC Program would find the
following information on Updating the Framework for AHRQ's National
Healthcare Quality and Disparities Report (NHQDR) helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this topic. In the list, please indicate whether results
are available on ClinicalTrials.gov along with the ClinicalTrials.gov
trial number.
[ssquf] For completed studies that do not have results on
ClinicalTrials.gov, a summary, including the following elements, if
relevant: study number, study period, design, methodology, indication
and diagnosis, proper use instructions, inclusion and exclusion
criteria, primary and secondary outcomes, baseline characteristics,
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this topic. In the list, please provide the
ClinicalTrials.gov trial number or, if the trial is not registered, the
protocol for the study including, if relevant, a study number, the
study period, design, methodology, indication and diagnosis, proper use
instructions, inclusion and exclusion criteria, and primary and
secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this topic and an index outlining the relevant information in each
submitted file.
Your contribution is very beneficial to the Program. Materials
submitted must be publicly available or able to be made public.
Materials that are considered confidential; marketing materials; study
types not included in the review; or information on topics not included
in the review cannot be used by the EPC Program. This is a voluntary
request for information, and all costs for complying with this request
must be borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program
website and available for public comment for a period of 4 weeks. If
you would like to be notified when the draft is posted, please sign up
for the email list at: https://www.effectivehealthcare.ahrq.gov/email-updates.
The review will answer the following questions. This information is
provided as background. AHRQ is not requesting that the public provide
answers to these questions.
Guiding Questions (GQ)
GQ1. Which frameworks have been developed or are used for quality
of care?
What settings, populations, and intended use were the
frameworks developed for?
How are the framework domains defined?
In what context have these frameworks been used?
How do these frameworks intersect with levers and tools
available to federal and state governments?
How are the frameworks and domains similar or different
from the 2010 NASEM framework?
GQ2. How should the 2010 NASEM framework and its domains be
updated?
How would existing AHRQ NHQDR measures be reorganized in
the updated framework and domains?
Are there available measures for new framework domains?
[cir] Describe measures in terms of their definition, population,
years available, geographic representation, data sources, and
supporting evidence.
[[Page 71867]]
Criteria for Inclusion/Exclusion of Studies in the Review
----------------------------------------------------------------------------------------------------------------
Domain Inclusion Exclusion
----------------------------------------------------------------------------------------------------------------
Population........................... Publications that address quality of Publications
care indicators, criteria, or benchmarks. We not addressing quality
will accept the authors' definition of quality of care and
of care. Quality indicators may include care publications not
processes-related measures (e.g., follow-up mentioning quality of
post discharge, continuity of care, medication care nor health equity
errors), heath services utilization measures as a central feature
(e.g., hospital readmission, emergency of a framework.
department visit), care satisfaction (e.g.,
patient satisfaction, care needs met, trust in
care provider), or health outcomes (e.g.,
mortality, physical functional status, mental
functioning, quality of life) used as quality
indicators. Publications that do not address
quality of care in detail but include quality
of care and health equity in a framework will
also be eligible. Care disparities may either
address differences in provided health
services, focus on care services or health
outcomes of priority populations.
Concept.............................. Publications that include a figure or Publications
detailed description of a framework of quality citing existing
of care or care disparities; frameworks may use frameworks without
the format of a logic model, analytic further conceptual
framework, conceptual model, or other contribution to the
conceptualizations of quality of care. framework and
publications
describing only the
need of quality of
care measures.
Context.............................. Healthcare, specifically healthcare Studies in
delivery organizations. contexts outside of
healthcare or not
specific to
healthcare.
Other limiters....................... Reports published in English-language, Data reported
journal manuscripts, trial records, and gray in abbreviated format
literature in the public domain from the (e.g., conference
outlined sources. abstracts) will be
excluded; studies not
published in English
Systematic
reviews will be
retained for reference
mining.
----------------------------------------------------------------------------------------------------------------
Dated: October 12, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-22915 Filed 10-17-23; 8:45 am]
BILLING CODE 4160-90-P
